Nanopublication: RARgQGnPsw

Full identifier: http://purl.org/np/RARgQGnPsw2Yi11ld7YAl_oP-yD2pYp4A8Cp5U_F3VgAI

Raw formats: TriG(html,txt), JSON-LD(txt), N-Quads(txt), XML(txt)

Checking for updates...

 RARgQGnPsw comment approve/disapprove edit as derived nanopublication create new with same template

This is a local identifier minted within the nanopublication. http://purl.org/np/RARgQGnPsw...#association This association http://www.w3.org/2000/01/rdf-schema#label has label (this is a literal) "zoladex is a gonadotropin releasing hormone gnrh agonist indicated for 1 1 1 2 1 3 1 4 1 5 zoladex is indicated for use in combination with flutamide for the management of locally confined stage t2b t4 stage b2 c carcinoma of the prostate treatment with zoladex and flutamide should start 8 weeks prior to initiating radiation therapy and continue during radiation therapy see dosage and administration 2 1 and clinical studies 14 1 zoladex is indicated in the palliative treatment of advanced carcinoma of the prostate see dosage and administration 2 2 clinical studies 14 2 zoladex is indicated for the management of endometriosis including pain relief and reduction of endometriotic lesions for the duration of therapy experience with zoladex for the management of endometriosis has been limited to women 18 years of age and older treated for 6 months see dosage and administration 2 3 clinical studies 14 3 zoladex is indicated for use as an endometrial thinning agent prior to endometrial ablation for dysfunctional uterine bleeding see dosage and administration 2 4 clinical studies 14 4 zoladex is indicated for use in the palliative treatment of advanced breast cancer in pre and perimenopausal women the estrogen and progesterone receptor values may help to predict whether zoladex therapy is likely to be beneficial see dosage and administration 2 6 clinical pharmacology 12 1 clinical studies 14 5 the automatic safety feature of the syringe aids in the prevention of needlestick injury" .
This is the identifier for this whole nanopublication. http://purl.org/np/RARgQGnPsw... This nanopublication date and time when the nanopublication was created http://purl.org/dc/terms/created was created on (this is a literal) "2021-06-30T09:02:23.100+02:00" .
This is the identifier for this whole nanopublication. http://purl.org/np/RARgQGnPsw... This nanopublication links to the assertion template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate was created from the assertion template http://purl.org/np/RAManV5GZI... RAManV5GZI .
This is the identifier for this whole nanopublication. http://purl.org/np/RARgQGnPsw... This nanopublication links to the provenance template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate was created from the provenance template http://purl.org/np/RANwQa4ICW... RANwQa4ICW .
This is the identifier for this whole nanopublication. http://purl.org/np/RARgQGnPsw... This nanopublication links to the publication info template that was used to create this nanopublication https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate was created from the publication info template http://purl.org/np/RAA2MfqdBC... RAA2MfqdBC .
This is a local identifier minted within the nanopublication. http://purl.org/np/RARgQGnPsw...#sig sig http://purl.org/nanopub/x/hasSignatureTarget has as target This is the identifier for this whole nanopublication. http://purl.org/np/RARgQGnPsw... this nanopublication .
This is a local identifier minted within the nanopublication. http://purl.org/np/RARgQGnPsw...#sig sig http://purl.org/nanopub/x/hasAlgorithm has the algorithm (this is a literal) "RSA" .

Leoni Bücken, 30 Jun 2021, 07:02:23 UTC

show references